β-Amyloid 12-20

β-Amyloid 12-20 is a synthetic peptide fragment derived from the amyloid beta (Aβ) protein, specifically encompassing residues 12 through 20 of the full-length sequence. As a well-characterized segment of the amyloid beta peptide, it holds significant relevance in biochemical and neurodegenerative research, particularly in studies related to protein aggregation, amyloidogenic pathways, and the molecular underpinnings of Alzheimer's disease. The sequence exhibits a propensity for self-association and aggregation, making it a valuable model for dissecting the physicochemical properties that drive amyloid formation. Its defined structure and solubility profile facilitate controlled experimental manipulation, supporting a wide range of peptide-focused investigations in both academic and industrial settings.

Aggregation studies: Researchers frequently employ the 12-20 fragment to investigate the intrinsic factors governing amyloid fibril formation. Due to its core hydrophobic motif, this peptide serves as a model system for elucidating the kinetics and thermodynamics of β-sheet assembly, nucleation events, and oligomerization processes. By isolating this specific region, scientists can dissect the minimal sequence requirements for aggregation and gain insight into the intermolecular interactions that stabilize amyloid structures, which are central to understanding the pathogenesis of protein misfolding diseases.

Structure-activity relationship analysis: The 12-20 region of amyloid beta is critical for probing structure-activity relationships within the broader peptide. Using this fragment, researchers can systematically introduce mutations, truncations, or chemical modifications to assess the impact on aggregation propensity, secondary structure, and biological interactions. Such studies enable the identification of key residues responsible for pathogenic conformational changes, supporting the rational design of aggregation inhibitors and the development of structure-based screening assays.

Inhibitor screening assays: The peptide is widely utilized in high-throughput screening platforms designed to identify small molecules, peptides, or other modulators that influence amyloid formation. Its well-defined aggregation behavior provides a robust and reproducible system for evaluating compound efficacy in disrupting β-sheet assembly or preventing oligomerization. These assays are essential for early-stage drug discovery efforts targeting amyloidogenic pathways, offering a reliable readout for compound optimization and mechanistic studies.

Biophysical characterization: The β-Amyloid 12-20 fragment is an ideal substrate for a range of biophysical techniques, including nuclear magnetic resonance (NMR) spectroscopy, circular dichroism (CD) spectroscopy, and atomic force microscopy (AFM). Its manageable size and aggregation profile enable detailed examination of conformational transitions, intermolecular contacts, and surface morphology of peptide assemblies. Such analyses provide fundamental insights into the molecular determinants of amyloid structure and dynamics, informing both basic research and applied development.

Peptide-based material science: Beyond neurodegenerative research, the aggregation properties of the 12-20 peptide fragment have utility in the design and fabrication of novel biomaterials. Its self-assembling characteristics are harnessed to create nanoscale structures, hydrogels, and scaffolds for applications in nanotechnology and tissue engineering. By leveraging the predictable assembly behavior of this sequence, researchers can engineer functional materials with tunable mechanical and biochemical properties, expanding the scope of peptide-driven innovation in material science.

1. Crystal Structure of BamB from Pseudomonas aeruginosa and Functional Evaluation of Its Conserved Structural Features

2. Identification, Localization in the Central Nervous System and Novel Myostimulatory Effect of Allatostatins in Tenebrio molitor Beetle

3. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis

4. Myotropic activity of allatostatins in tenebrionid beetles

5. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation